Orthofix Medical Inc. Common Stock (DE) (OFIX)
Orthofix Medical Inc. (OFIX) is a global medical device company specializing in musculoskeletal solutions, including spine, sports, and minimally invasive procedures. Founded in 1987, the company develops and markets products such as spinal implants, devices for bone healing, and treatments for orthopedic conditions, serving physicians and patients worldwide.
Company News
Orthofix Medical reported Q2 2025 financial results, beating earnings estimates with $203.1 million in revenue, representing 2.3% year-over-year growth. The company saw segment gains in Bone Growth Therapies and Orthopedics, with positive free cash flow and continued new product execution.
The global intramedullary nail market is expected to grow rapidly, driven by the rising incidence of bone fractures, particularly among the aging population, and advancements in surgical techniques. However, the market faces challenges such as high procedural costs, the need for skilled professionals, and competition from alternative fixation dev...
Orthofix Medical Inc. is facing a securities fraud lawsuit for allegedly making false and misleading statements to the market regarding certain members of its management team engaging in inappropriate conduct. The lawsuit seeks to represent investors who purchased the company's securities during the class period.
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
Orthofix Medical investors suffered their worst day in 28 years on Tuesday after the spine and orthopedics company fired three top executives "for cause."
